Our study provides more evidence for a better understanding of the crosstalk between bone and CNS, and expands the neuroprotective roles of OCN in AD, suggesting that OCN or its derived analogs may be explored as a potential therapeutic approach in neurodegenerative diseases like AD. Here, BGLAP is linked to neurodegenerative disease.